Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT

BACKGROUND: Aclidinium/formoterol 400/12 µg is a twice-daily maintenance bronchodilator for COPD. This post hoc study evaluated aclidinium/formoterol vs aclidinium 400 µg, formoterol 12 µg, or placebo in patient subgroups. PATIENTS AND METHODS: Data were pooled from two 24-week Phase III clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Urzo, Anthony D, Singh, Dave, Donohue, James F, Kerwin, Edward M, Ribera, Anna, Molins, Eduard, Chuecos, Ferran, Jarreta, Diana, Gil, Esther Garcia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396834/
https://www.ncbi.nlm.nih.gov/pubmed/30880938
http://dx.doi.org/10.2147/COPD.S185502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396834/
https://www.ncbi.nlm.nih.gov/pubmed/30880938
http://dx.doi.org/10.2147/COPD.S185502

Ejemplares similares